Microbot Medical (MBOT) has partnered with a U.S. based third-party logistics, 3PL, company to support the commercialization of the FDA-cleared LIBERTY System. The Company is expected to initiate the limited market release of the LIBERTY System during the current fourth quarter of 2025 with the broader launch anticipated to occur in April 2026 during the Society of Interventional Radiology conference, which is the largest Interventional Radiology conference in the U.S.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MBOT:
- Microbot Medical files to sell 900,153 shares of common stock for holders
- Microbot Medical files to sell 14.69M shares of common stock for holders
- Microbot Medical Completes Final Closing of Investment Options
- Microbot Medical closes exercise of outstanding preferred investment options
- Microbot Medical Announces Series H Options Exercise